What corrective actions has Neurocept announced in response to BBB complaints since 2023?
Executive summary
Neurocept has multiple BBB listings and numerous consumer reports on BBB’s Scam Tracker alleging deceptive marketing, AI-generated endorsements, and poor customer service; those complaint pages show consumer allegations but do not include company-authored corrective action announcements in the BBB records available here (BBB profile and Scam Tracker entries) [1] [2]. Independent review sites and press-style pieces accuse Neurocept of using fake celebrity endorsements and deepfakes, but available sources do not show a public Neurocept statement to the BBB describing corrective actions since 2023 [3] [4].
1. What the BBB records actually show — complaints, not corrective plans
BBB profile pages list Neurocept (and a variant spelling “Neuerocept”) and point users to complaint summaries, reviews and Scam Tracker posts; they mark the business as not BBB accredited and do not present a clear company timeline of remediation steps or formal corrective actions in the entries cited here [1] [5]. The Scam Tracker item documents a consumer report that the sales pitch used convincing AI content and that follow-up texts after purchase looked like scam notifications — this is a consumer allegation, not a company response or corrective plan [2].
2. Consumers report deception and poor post‑sale handling
Multiple customer posts compiled on Trustpilot and BBB Scam Tracker describe experiences of being misled by marketing, difficulty cancelling or getting refunds, and contested charges; one Trustpilot reviewer says they notified the BBB and filed a credit‑card dispute, and Scam Tracker users recount receiving multiple confusing texts after purchase [3] [2]. Those complaints form the factual basis for calls for corrective action but do not document any admitted fixes taken by Neurocept in the BBB sources [3] [2].
3. Media and blog investigations allege deepfake marketing tactics
Reporting and reviews found in the provided selection argue that Neurocept’s advertising borrows the likenesses of trusted media figures (e.g., Dr. Sanjay Gupta) and that video ads may be AI‑generated deepfakes; one analysis explicitly frames Neurocept’s marketing as a “deepfake scam” and says purported celebrity endorsements were never given [4]. CNN later published a story about Dr. Gupta denouncing AI use in fake product ads, illustrating the broader problem of deceptive health advertising using public figures — but the CNN piece does not record Neurocept’s corrective actions to the BBB specifically [6].
4. Regulatory and historical context: similar supplement marketers faced enforcement
Federal trade enforcement has a history of action against supplement marketers who used fake endorsements and deceptive claims; the FTC announced actions (earlier cases named Neurocet and others) alleging marketers used fake doctor endorsements and false health promises — this context shows why BBB complaints about Neurocept’s ads attract scrutiny, but the FTC action referenced is about different defendants and predates the current Neurocept complaints list [7]. Available sources do not show an FTC action against the Neurocept entries cited here [7].
5. What is missing from the public record in these sources
The BBB pages and consumer posts document allegations and customer experiences but do not contain a Neurocept-authored corrective action plan, a formal BBB response describing policy changes, or documented remediation (refund programs, ad corrections, or third‑party audits) since 2023. If Neurocept announced corrective steps to the BBB or publicly posted a remediation timeline, those announcements are not present in the sources provided [1] [2] [5].
6. Competing narratives and how to interpret them
Company promotional pages and some 2025 PR-style articles present Neurocept as an evidence‑based brain supplement and position it positively, emphasizing formulation and benefits [8] [9]. Consumer watchdog posts and investigative pieces argue the product’s marketing is deceptive and may rely on AI‑manufactured endorsements [3] [4]. The sources supplied do not reconcile these narratives with a documented, company-led corrective action record submitted to the BBB [1] [2].
7. What to do next if you need confirmation of corrective actions
Based on the gaps in these records, the prudent next steps are: request Neurocept’s communications to BBB directly, ask the BBB for the company’s response history on the specific complaint files, or seek any press releases from Neurocept addressing the allegations. The provided sources do not show such communications or official corrective measures within the BBB entries available here [1] [2].
Limitations: reporting above relies solely on the provided BBB pages, Scam Tracker entries, consumer reviews and investigative blog posts; if Neurocept posted corrective actions elsewhere (press release, website notice, or direct BBB response) those items were not in the supplied sources and thus are not reflected here [1] [2] [4].